Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Secures Credit Facility of up to $200M

NEW YORK (GenomeWeb) – Bio-Rad Laboratories said on Thursday it has entered into a credit agreement with lenders to borrow up to $200 million.

In a document filed with the US Securities and Exchange Commission, Bio-Rad said the agreement is with JP Morgan Chase Bank, as the administrative agent; Union Bank and Wells Fargo Bank, National Association as co-syndication agents; and the Bank of America and HSBC Bank USA, National Association as co-documentation agents.

Bio-Rad can borrow a maximum of $200 million on a revolving basis, including up to $25 million of swingline loans, and up to $50 million of letters of credit. The total amount of the borrowings can be increased by an additional $200 million if the lenders consent to certain conditions.

Funds from the credit facility may be used for acquisitions, working capital, and other general corporate purposes. The agreement matures on June 20, 2019, although it may be extended up to three times if mutually agreed upon by Bio-Rad and the lenders.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.